Cann Group delivers ‘modest’ growth as imports continue to frustrate by Steve Jones February 1, 2024February 1, 2024 Increased market pressure caused by overseas imports led to slower growth for Cann Group in the […]
Company news: Clever Leaves; Cronos/Vitura; InhaleRX; Emyria; CannMart/Aura Therapeutics; Cann Group; Greenfern Industries; LGP/Reset Mind Sciences by Steve Jones and Martin Lane January 16, 2024January 17, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023December 8, 2023
Cann Group inks deal to raise A$2m with more funds on the horizon by Steve Jones November 21, 2023November 23, 2023
Decriminalise home-grown cannabis but full legal market ‘worries the hell out of me’, says Cann Group boss by Steve Jones November 7, 2023November 7, 2023
Cann Group doubles revenue but ASX again seeks reassurance over finances by Steve Jones October 31, 2023October 31, 2023
TGA to stick with 150mg dose of CBD amid Cann Group ‘surprise’ at UK advice by Steve Jones October 25, 2023October 26, 2023
Company news: Breathe Life Sciences; Cann Group; InhaleRx; X-Hemp; Green Farmers/Elevated Signals by Martin Lane October 19, 2023October 19, 2023